共 50 条
- [22] Addition of Daratumumab to Drug Regimens in the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Clinical Trials CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S405 - S405
- [25] Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical Trials CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (01): : 32 - 44
- [27] Efficacy of daratumumab combination regimen in patients with multiple myeloma: A combined analysis of phase III randomized controlled trials EJHAEM, 2020, 1 (01): : 262 - 266
- [28] Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients With Multiple Myeloma CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (09): : E579 - E589
- [29] Risk of Renal Toxicities With Carfilzomib In Patients With Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S332 - S332